Reduced tumor formation in Bcl-3Hep mice at 40 weeks of age was associated with a decrease in cell proliferation and inflammation in the liver, and accompanied by reduced injurious mitogen-activated protein kinases (MAPK) and enhanced NF-κB signaling pathways. Here, NFKB1 is linked to neoplasm.